ICAD Inc: Rises on upbeat Q1 revenue forecast

icad

06/04/2021 17:14

** Shares of medical-device manufacturer  ICAD.O  rise 5.1%
to $20.91
    ** ICAD on Monday aftermarket said it expected Q1 rev. to
exceed $8.1 mln, above analysts' estimates of $7.9 mln according
to Refinitiv IBES data  urn:newsml:reuters.com:*:nGNX8hwbrS
    ** ICAD Chief Financial Officer to leave in early May to
accept a position with another company; search and selection
process for a successor underway - co
    ** BTIG says with a solid Q1 performance in hand, it remains
bullish on ICAD
    ** Current avg. recommendation on stock is "buy"; median PT
is $23
    ** ICAD shares up 50.8% this year, as of last close
    

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))